TrialThe Journal of infectious diseases2016

Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections.

Ariana Harari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.